Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' VaccineCEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
